keyword
https://read.qxmd.com/read/32523310/treatment-of-gastrointestinal-bleeding-in-left-ventricular-assist-devices-a-comprehensive-review
#21
REVIEW
Srikanth Vedachalam, Gokulakrishnan Balasubramanian, Garrie J Haas, Somashekar G Krishna
Left ventricular assist devices (LVAD) are increasingly become common as life prolonging therapy in patients with advanced heart failure. Current devices are now used as definitive treatment in some patients given the improved durability of continuous flow pumps. Unfortunately, continuous flow LVADs are fraught with complications such as gastrointestinal (GI) bleeding that are primarily attributed to the formation of arteriovenous malformations. With frequent GI bleeding, antiplatelet and anticoagulation therapies are usually discontinued increasing the risk of life-threatening events...
May 28, 2020: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/32493133/human-menstrual-blood-derived-mesenchymal-cells-improve-mouse-embryonic-development
#22
JOURNAL ARTICLE
Marianna Ferreira Gonçalves, Karina Dutra Asensi, Anna Luiza Lima Nascimento, Julia Helena Oliveira de Barros, Rosana de Almeida Santos, Cherley Borba Vieira de Andrade, Tais Hanae Kasai-Brunswick, Marcel Frajblat, Tania M Ortiga-Carvalho, Regina Coeli Dos Santos Goldenberg
There is a constant need for improving embryo culture conditions in assisted reproduction. One possibility is to use mesenchymal stem/stromal cells derived from menstrual blood (mbMSCs), with an endometrial origin. In this study, we sought to analyze the expansion of mouse embryos in a direct coculture model with mbMSCs. Our results showed that after five passages, mbMSCs presented a spindle-shaped morphology, with surface markers that were comparable with the normal mesenchymal cell phenotype. mbMSCs could differentiate into adipogenic and osteogenic lineages and secrete angiopoetin-2 and hepatocyte growth factor...
July 2020: Tissue Engineering. Part A
https://read.qxmd.com/read/32465303/donor-derived-cell-free-dna-does-not-correlate-with-levels-of-inflammation-or-angiogenesis-in-a-stable-post-transplant-population
#23
JOURNAL ARTICLE
L Holzhauser, T Fujino, A Nguyen, F Alenghat, J Raikhelkar, G Kim, G Sayer, N Uriel
PURPOSE: Donor-derived cell-free DNA (dd-cfDNA) has recently been introduced as a novel marker of acute cellular and antibody mediated rejection. We hypothesized that levels of dd-cfDNA would correlate with markers of chronic inflammation and angiogenesis in a stable post-transplant population. METHODS: 65 heart transplant recipients who were 8.5±5.4 years post transplant were enrolled at routine clinic visits. Exclusion criteria for the study were episodes of rejection within 6 months or recent infection...
April 2020: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/32458111/angiopoietin-2-as-a-marker-of-endothelial-activation-is-a-good-predictor-factor-for-intensive-care-unit-admission-of-covid-19-patients
#24
JOURNAL ARTICLE
David M Smadja, Coralie L Guerin, Richard Chocron, Nader Yatim, Jeremy Boussier, Nicolas Gendron, Lina Khider, Jérôme Hadjadj, Guillaume Goudot, Benjamin Debuc, Philippe Juvin, Caroline Hauw-Berlemont, Jean-Loup Augy, Nicolas Peron, Emmanuel Messas, Benjamin Planquette, Olivier Sanchez, Bruno Charbit, Pascale Gaussem, Darragh Duffy, Benjamin Terrier, Tristan Mirault, Jean-Luc Diehl
BACKGROUND: Coronavirus disease-2019 (COVID-19), a respiratory disease has been associated with ischemic complications, coagulation disorders, and an endotheliitis. OBJECTIVES: To explore endothelial damage and activation-related biomarkers in COVID-19 patients with criteria of hospitalization for referral to intensive care unit (ICU) and/or respiratory worsening. METHODS: Analysis of endothelial and angiogenic soluble markers in plasma from patients at admission...
November 2020: Angiogenesis
https://read.qxmd.com/read/32162804/the-mccave-trial-vanucizumab-plus-mfolfox-6-versus-bevacizumab-plus-mfolfox-6-in-patients-with-previously-untreated-metastatic-colorectal-carcinoma-mcrc
#25
JOURNAL ARTICLE
Johanna C Bendell, Tamara Sauri, Antonio Cubillo Gracián, Rafael Alvarez, Carlos López-López, Pilar García-Alfonso, Maen Hussein, Maria-Luisa Limon Miron, Andrés Cervantes, Clara Montagut, Cristina Santos Vivas, Alberto Bessudo, Patricia Plezia, Veerle Moons, Johannes Andel, Jaafar Bennouna, Andre van der Westhuizen, Leslie Samuel, Simona Rossomanno, Christophe Boetsch, Angelika Lahr, Izolda Franjkovic, Florian Heil, Katharina Lechner, Oliver Krieter, Herbert Hurwitz
BACKGROUND: Bevacizumab, a VEGF-A inhibitor, in combination with chemotherapy, has proven to increase progression-free survival (PFS) and overall survival in multiple lines of therapy of metastatic colorectal cancer (mCRC). The angiogenic factor angiopoetin-2 (Ang-2) is associated with poor prognosis in many cancers, including mCRC. Preclinical models demonstrate improved activity when inhibiting both VEGF-A and Ang-2, suggesting that the dual VEGF-A and Ang-2 blocker vanucizumab (RO5520985 or RG-7221) may improve clinical outcomes...
March 2020: Oncologist
https://read.qxmd.com/read/31781660/effects-of-negative-pressure-wound-therapy-on-levels-of-angiopoetin-2-and-other-selected-circulating-signaling-molecules-in-patients-with-diabetic-foot-ulcer
#26
JOURNAL ARTICLE
Jerzy Hohendorff, Anna Drozdz, Sebastian Borys, Agnieszka H Ludwig-Slomczynska, Beata Kiec-Wilk, Ewa L Stepien, Maciej T Malecki
BACKGROUND AND AIMS: Diabetic foot ulcers (DFUs) are linked to amputations and premature deaths. Negative pressure wound therapy (NPWT) has been used for DFUs. The mechanism of NPWT's action may be associated with its influence on circulating molecules. We assessed NPWT's effect on the plasma levels of angiopoietin-2 (Ang2), a key regulator of angiogenesis, and its microvesicular receptors (Tie2) as well as the microvesicles (MVs) themselves in DFU patients. MATERIALS AND METHODS: We included 69 patients with type 2 diabetes mellitus (T2DM) and neuropathic, noninfected DFUs-49 were treated with NPWT and 20 were treated with standard therapy (ST)...
2019: Journal of Diabetes Research
https://read.qxmd.com/read/31570519/the-mccave-trial-vanucizumab-plus-mfolfox-6-versus-bevacizumab-plus-mfolfox-6-in-patients-with-previously-untreated-metastatic-colorectal-carcinoma-mcrc
#27
JOURNAL ARTICLE
Johanna C Bendell, Tamara Sauri, Antonio Cubillo Gracián, Rafael Alvarez, Carlos López-López, Pilar García-Alfonso, Maen Hussein, Maria-Luisa Limon Miron, Andrés Cervantes, Clara Montagut, Cristina Santos Vivas, Alberto Bessudo, Patricia Plezia, Veerle Moons, Johannes Andel, Jaafar Bennouna, Andre van der Westhuizen, Leslie Samuel, Simona Rossomanno, Christophe Boetsch, Angelika Lahr, Izolda Franjkovic, Florian Heil, Katharina Lechner, Oliver Krieter, Herbert Hurwitz
BACKGROUND: Bevacizumab, a VEGF-A inhibitor, in combination with chemotherapy, has proven to increase progression-free survival (PFS) and overall survival in multiple lines of therapy of metastatic colorectal cancer (mCRC). The angiogenic factor angiopoetin-2 (Ang-2) is associated with poor prognosis in many cancers, including mCRC. Preclinical models demonstrate improved activity when inhibiting both VEGF-A and Ang-2, suggesting that the dual VEGF-A and Ang-2 blocker vanucizumab (RO5520985 or RG-7221) may improve clinical outcomes...
September 30, 2019: Oncologist
https://read.qxmd.com/read/31512003/association-of-endothelial-and-glycocalyx-injury-biomarkers-with-fluid-administration-development-of-acute-kidney-injury-and-90-day-mortality-data-from-the-finnaki-observational-study
#28
JOURNAL ARTICLE
Nina Inkinen, Ville Pettilä, Päivi Lakkisto, Anne Kuitunen, Sakari Jukarainen, Stepani Bendel, Outi Inkinen, Tero Ala-Kokko, Suvi T Vaara
BACKGROUND: Injury to endothelium and glycocalyx predisposes to vascular leak, which may subsequently lead to increased fluid requirements and worse outcomes. In this post hoc study of the prospective multicenter observational Finnish Acute Kidney Injury (FINNAKI) cohort study conducted in 17 Finnish intensive care units, we studied the association of Syndecan-1 (SDC-1), Angiopoetin-2 (Ang-2), soluble thrombomodulin (sTM), vascular adhesion protein-1 (VAP-1) and interleukin-6 (IL-6) with fluid administration and balance among septic critical care patients and their association with development of acute kidney injury (AKI) and 90-day mortality...
September 11, 2019: Annals of Intensive Care
https://read.qxmd.com/read/31453986/protective-effects-of-plasma-products-on-the-endothelial-glycocalyx-barrier-following-trauma-hemorrhagic-shock-is-sphingosine-1-phosphate-responsible
#29
JOURNAL ARTICLE
Mark E Diebel, Lawrence N Diebel, David M Liberati
BACKGROUND: Plasma is an important component of resuscitation after trauma and hemorrhagic shock (T/HS). The specific plasma proteins and the impact of storage conditions are uncertain. Utilizing a microfluidic device system, we studied the effect of various types of plasma on the endothelial barrier function following T/HS. METHODS: Human umbilical vein endothelial cells (HUVEC) were cultured in microfluidic plates. The microfluidic plates were subjected to control or shock conditions (hypoxia/reoxygenation + epinephrine, 10 μM)...
November 2019: Journal of Trauma and Acute Care Surgery
https://read.qxmd.com/read/31041507/identification-of-placental-genes-linked-to-selective-intrauterine-growth-restriction-iugr-in-dichorionic-twin-pregnancies-gene-expression-profiling-study
#30
JOURNAL ARTICLE
Lidia Biesiada, Agata Sakowicz, Mariusz Grzesiak, Maciej Borowiec, Michalina Lisowska, Tadeusz Pietrucha, Constantin von Kaisenberg, Krzysztof Lewandowski
A linkage of dichorionic (DC) twin pregnancies with selective intrauterine growth restriction (IUGR) to alterations in placental gene expression is unclear. The aim of the study was to identify placental genes related to hypoxia, adipogenesis and human growth which may contribute to IUGR development. The study group (IUGR/AGA) comprised dichorionic (DC) twin pregnancies, where the weight of the twins differed by > 15%; in addition, one twin was small for gestational age (< 10th percentile-SGA) (IUGR) while the other was appropriate for gestational age (> 10th percentile-AGA)...
June 2019: Human Genetics
https://read.qxmd.com/read/31004588/do-third-molars-contribute-to-systemic-inflammation-results-from-a-population-based-study-from-northeast-germany
#31
JOURNAL ARTICLE
Stefan Kindler, Maria Mksoud, Birte Holtfreter, Nele Friedrich, Robin Bülow, Till Ittermann
PURPOSE: Erupted and impacted third molars have been reported to contribute to systemic inflammation. This study investigated the systemic effect of third molars on serum levels of inflammatory parameters and on inflammatory messenger peptide hormones in a general population sample. MATERIALS AND METHODS: Data of 2,151 participants from the Study of Health in Pomerania were included in this study. Erupted or impacted third molars were assessed with whole-body magnetic resonance imaging at 1...
August 2019: Journal of Oral and Maxillofacial Surgery
https://read.qxmd.com/read/30002415/o-glcnacylation-of-foxo1-mediates-nucleoside-diphosphate-kinase-b-deficiency-induced-endothelial-damage
#32
JOURNAL ARTICLE
Shenliang Shan, Anupriya Chatterjee, Yi Qiu, Hans-Peter Hammes, Thomas Wieland, Yuxi Feng
Nucleoside diphosphate kinase B (NDPK-B) acts as a protective factor in the retinal vasculature. NDPK-B deficiency leads to retinal vasoregression mimicking diabetic retinopathy (DR). Angiopoetin 2 (Ang-2), an initiator of retinal vasoregression in DR, is upregulated in NDPK-B deficient retinas and in NDPK-B depleted endothelial cells (ECs) in vitro. We therefore investigated the importance of Ang-2 in NDPK-B deficient retinas and characterized the mechanisms of Ang-2 upregulation upon NDPK-B depletion in cultured ECs...
July 12, 2018: Scientific Reports
https://read.qxmd.com/read/29397265/the-evaluation-of-circulating-endothelial-progenitor-cells-and-related-angiogenic-markers-as-prognostic-factors-in-soft-tissue-tumors
#33
JOURNAL ARTICLE
Ioannis Karampinis, Elena Joas, Anna Dreyer, Ulrich Ronellenfitsch, Jens Jakob, Peter Hohenberger, Kai Nowak
INTRODUCTION: Neovascularisation is a critical step in the progression of malignant tumors. Circulating endothelial progenitor cells (cEPC) have been proposed as surrogate markers of vasculogenesis in malignancies. In this project, we studied the impact of tumor-specific therapy on cEPC and associated angiogenic factors in patients with soft tissue tumors. MATERIALS AND METHODS: Fifty-three patients with soft tissue tumors (25 soft tissue sarcomas, 19 GIST, 9 desmoids) and 15 healthy controls were included...
April 2018: European Journal of Surgical Oncology
https://read.qxmd.com/read/29225901/immediate-response-in-markers-of-inflammation-and-angiogenesis-during-exercise-a-randomised-cross-over-study-in-heart-transplant-recipients
#34
JOURNAL ARTICLE
Marianne Yardley, Thor Ueland, Pål Aukrust, Annika Michelsen, Elisabeth Bjørkelund, Lars Gullestad, Kari Nytrøen
Background: The present study explored and compared the immediate responses in markers of inflammation and angiogenesis in maintenance heart transplant (HTx) recipients before, during and after sessions of high-intensity interval training (HIT) versus moderate-intensity continuous training (MICT). The study aimed to explain some of the trigger mechanisms behind HIT in HTx recipients. Methods: This cross-over study included 14 HTx patients (mean±SD age: 53±13 years; time since HTx, 3±2 years)...
2017: Open Heart
https://read.qxmd.com/read/28443023/inhibition-of-vegf-and-angiopoietin-2-to-reduce-brain-metastases-of-breast-cancer-burden
#35
JOURNAL ARTICLE
Kaci A Bohn, Chris E Adkins, Mohamed I Nounou, Paul R Lockman
For metastases in the central nervous system, angiogenesis enhances metastatic potential and promotes progression. Primary factors which drive vessel growth are vascular endothelial growth factor (VEGF) and angiopoietin-2. Preclinical models show inhibition of either factor reduces metastases spread and inhibits growth. This work sets out to answer two questions in a preclinical mouse model. First, whether the combined inhibition of VEGF and angiopoietin-2, reduces passive permeability and limits drug uptake into brain metastases; and second, whether this inhibition reduces metastases burden in brain...
2017: Frontiers in Pharmacology
https://read.qxmd.com/read/28422724/utilizing-combinatorial-engineering-to-develop-tie2-targeting-antagonistic-angiopoetin-2-ligands-as-candidates-for-anti-angiogenesis-therapy
#36
JOURNAL ARTICLE
Tomer Shlamkovich, Lidan Aharon, William A Barton, Niv Papo
In many human cancers, the receptor tyrosine kinase (RTK) Tie2 plays important roles in mediating proliferation, survival, migration and angiogenesis. Thus, molecules that could potently inhibit activation of the Tie2 receptor would have a significant impact on cancer therapy. Nevertheless, attempts to develop Tie2-targeted inhibitors have met with little success, and there is currently no FDA-approved therapeutic selectively targeting Tie2. We used a combinatorial protein engineering approach to develop a new generation of angiopoietin (Ang)2-derived Tie2 antagonists as potential cancer therapeutics and as tools to study angiogenesis...
May 16, 2017: Oncotarget
https://read.qxmd.com/read/28045067/microvasculature-remodeling-in-the-mouse-lower-gut-during-inflammaging
#37
JOURNAL ARTICLE
Jae-Ho Jeong, KwangSoo Kim, Daejin Lim, Kun-Hee Kim, Hyung-Seok Kim, Sungsu Lee, Joo-Hye Song, Byoung-Gon Moon, Hyon E Choy, Sang Chul Park
Inflammaging is defined as low-grade, chronic, systemic inflammation in aging, in the absence of overt infection. Age-associated deterioration of gastrointestinal function could be ascribed to the inflammaging, although evidence is yet to emerge. Here we show that microvessels in aging mouse intestine were progressively deprived of supportive structures, microvessel-associated pericytes and adherens junction protein vascular endothelial (VE)-cadherin, and became leaky. This alteration was ascribed to up-regulation of angiopoetin-2 in microvascular endothelial cells...
January 3, 2017: Scientific Reports
https://read.qxmd.com/read/27617438/angiopoetin-2-signals-do-not-mediate-the-hypervascularization-of-islets-in-type-2-diabetes
#38
JOURNAL ARTICLE
Payal Shah, Navina Lueschen, Amin Ardestani, Jose Oberholzer, Johan Olerud, Per-Ola Carlsson, Kathrin Maedler
AIMS: Changes in the islet vasculature have been implicated in the regulation of β-cell survival and function during the progression to type 2 diabetes (T2D). Failure of the β-cell to compensate for the increased insulin demand in obesity eventually leads to diabetes; as a result of the complex interplay of genetic and environmental factors (e.g. ongoing inflammation within the islets) and impaired vascular function. The Angiopoietin/Tie (Ang/Tie) angiogenic system maintains vasculature and is closely related to organ inflammation and angiogenesis...
2016: PloS One
https://read.qxmd.com/read/25982018/effect-of-different-enamel-matrix-derivative-proteins-on-behavior-and-differentiation-of-endothelial-cells
#39
JOURNAL ARTICLE
Oleh Andrukhov, Anja C Gemperli, Yan Tang, Nadia Howald, Michel Dard, Frank Falkensammer, Andreas Moritz, Xiaohui Rausch-Fan
OBJECTIVES: Enamel matrix derivative (EMD) is an effective biomaterial for periodontal tissue regeneration and might stimulate angiogenesis. In order to clarify mechanisms underlying its biological activity, we separated two EMD fractions with different molecular weight protein components and investigated their effects on human umbilical vein endothelial cells (HUVECs) in vitro. METHODS: Fraction Low-Molecular Weight (LMW) included proteins with a molecular weight (M...
July 2015: Dental Materials
https://read.qxmd.com/read/25909285/foretinib-inhibits-angiogenesis-lymphangiogenesis-and-tumor-growth-of-pancreatic-cancer-in-vivo-by-decreasing-vegfr-2-3-and-tie-2-signaling
#40
JOURNAL ARTICLE
Hsiu-Mei Chen, Chia-Hua Tsai, Wen-Chun Hung
Foretinib, a multiple kinase inhibitor undergoing clinical trials, could suppress the activity of hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor-2 (VEGFR-2). In addition, Foretinib may inhibit two critical lymphangiogenic signaling receptors VEGFR-3 and TIE-2. However, the effect of Foretinib on lymphatic endothelial cells (LECs) in vitro and lymphangiogenesis in vivo is still unknown. We found Foretinib decreased basal- and HGF-induced c-MET activity at low concentrations...
June 20, 2015: Oncotarget
keyword
keyword
49140
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.